Does α1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary α1-antitrypsin deficiency?

European Respiratory Journal

Volumn 10, Issue 10, 1997, Pages 2260-2263

  Seersholm, N ^a,d   Wencker, M ^b   Banik, N ^c   Viskum, K ^a   Dirksen, A ^a   Kok Jensen, A ^a   Konietzko, N ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b RUHRLANDKLINIK   (Germany)

^c BAYER AG   (Germany)

^d NONE   (Denmark)

Author keywords

1 antitrypsin deficiency; Augmentation therapy; Decline in lung function; Emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; DENMARK; DRUG EFFECT; DRUG EFFICACY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FOLLOW UP; GENETICS; GERMANY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; TREATMENT OUTCOME;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CONFIDENCE INTERVALS; DENMARK; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0031242842     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10102260     Document Type: Article

References (16)

1. 1-antitrypsin deficiency and pulmonary emphysema: the role of proteolytic enzymes and their inhibitors. Br J Dis Chest 1973; 67: 171-196.
2. 1-protease inhibitor deficiency. Am J Med 1988; 84(6A): 3-12.
3. 1-antitrypsin deficiency, PiZ. Acta Med Scand 1978; 204: 345-351.
4. 1-antitrypsin deficiency with special reference to nonindex cases. Thorax 1994; 49: 695-698.
5. 1-antitrypsin deficiency, type PiZ. Am J Respir Crit Care Med 1995; 152: 1922-1925.
6. 1-antitrypsin deficiency. Am J Med 1988; 84(6A): 52-62.
7. 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316: 1055-1062.
8. 1-antitrypsin deficiency: reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 1981; 68: 1158-1165.
9. 1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease. Am J Med 1988; 84: 63-69.
10. Burrows B. A clinical trial of efficacy of antiproteolytic therapy: can it be done? Am Rev Respir Dis 1983; 127: S42-S43.
11. 1-antitrypsin; design and methods. Chest 1994; 106: 1223-1232.
12. Quanjer PH. Standardized lung function testing. Eur Respir J 1993; 6: Suppl. 16, 3-102.
13. American Thoracic Society. A statement by the Committee on Standards for Epidemiology Surveys on Chronic Respiratory Disease of the American Thoracic Society. New York, National Tuberculosis and Respiratory Disease Association, 1969.
14. 1-antitrypsin. Adv Human Genet 1981; 11: 1-62.
15. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 964-974.
16. Jennrich RI, Schluchter MD. Unbalanced repeated measures models with structured covariance matrices. Biometrics 1996; 42: 805-820.